Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab
Clinical trial NCT02845999 · COMPLETED
Trial details
- NCT number
- NCT02845999
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.